Loading...
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
PURPOSE: Axicabtagene ciloleucel (axi-cel) is a CD19-directed chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma. Bridging therapy may be required for lymphoma control during the manufacturing interval between collection of autologous T cells and...
Na minha lista:
| Udgivet i: | Int J Radiat Oncol Biol Phys |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6872916/ https://ncbi.nlm.nih.gov/pubmed/31175906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.05.065 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|